GA
RMD icon

GraniteShares Advisors’s ResMed RMD Stock Holding History

GraniteShares Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$560K Sell
2,496
-431
-15% -$107K 0.4% 69
2025
Q4 		$705K Buy
2,927
+350
+14% +$89.5K 0.43% 73
2025
Q3 		$705K Sell
2,577
-91
-3% -$24.9K 0.41% 70
2025
Q2 		$688K Sell
2,668
-50
-2% -$11.9K 0.42% 70
2025
Q1 		$608K Sell
2,718
-57
-2% -$13.3K 0.39% 69
2024
Q4 		$635K Buy
+2,775
New +$668K 0.4% 71
2023
Q4 		– Sell
-4,001
Closed -$592K – 108
2023
Q3 		$592K Buy
+4,001
New +$723K 0.55% 72
2022
Q1 		– Sell
-691
Closed -$179K – 270
2021
Q4 		$179K Buy
+691
New +$179K 0.08% 203

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GraniteShares Advisors's RMD Position: Q1 2026 in Review

GraniteShares Advisors reduced its ResMed (RMD) stake by 15% in Q1 2026, selling an estimated $107K and leaving 2,496 shares worth $560K. The position accounts for 0.4% of the portfolio, ranked #69.

GraniteShares Advisors first reported a position in RMD in Q4 2021 and has held it in 8 quarters since. The position peaked at $705K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • GraniteShares Advisors held 2,496 shares of ResMed worth $560K as of Q1 2026.
  • GraniteShares Advisors sold 431 ResMed shares in Q1 2026, an estimated $107K.
  • ResMed made up 0.4% of GraniteShares Advisors's portfolio in Q1 2026, its #69 holding.
  • GraniteShares Advisors first reported a position in ResMed in Q4 2021 and has held it in 8 quarters since.
  • GraniteShares Advisors's ResMed position peaked at $705K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on GraniteShares Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.